Menu
← Oncology Approval Tracker
FDA DECISION ·
Kimmtrak
tebentafusp-tebn · Immunocore
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with HLA-A*02:01-positive uveal melanoma that is unresectable or metastatic.
LAMPGEN ANALYSIS
Why it matters
A gp100-directed T-cell engager introduces an HLA-selected treatment for advanced uveal melanoma.
What research teams should watch
Confirm HLA typing before referral and plan the required monitoring during initial infusions.
Related study operations checklist
See the staffing responsibilities, timing, and handoff questions for this study setting.
HLA-selected metastatic uveal melanomaPRIMARY RECORDS